Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Stereotactic Radiosurgery in Conjunction With the PD-1 Inhibitor, Pembrolizumab for the Treatment of Recurrent Meningioma

NCT04659811 is registered in ClinicalTrials.gov with Nancy Ann Oberheim Bush, MD as lead sponsor.

NCT NCT04659811
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04659811 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Stereotactic Radiosurgery in Conjunction With the PD-1 Inhibitor, Pembrolizumab for the Treatment of Recurrent Meningioma
Lead sponsor
Nancy Ann Oberheim Bush, MD
Phase
Phase 2
Overall status
Active, not recruiting
Start date
March 25, 2021
Completion date
March 31, 2031
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

grade i meningioma, adult, grade ii meningioma, adult, grade iii meningioma, adult, recurrent meningioma